Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lucerna
AddedFeb 18, 2024
UpdatedJun 18, 2026
Lucerna

Lucerna

Lucerna, Inc.: A NY-based biotech firm innovating in RNA imaging and drug discovery through fluorescent aptamer technology.

HQ
New York City, NY, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Lucerna, Inc., founded in 2010 and based in New York, is a biotechnology company dedicated to advancing RNA imaging and drug discovery. The company's core mission is to lead the market in developing RNA-based research reagents, leveraging their proprietary fluorescent aptamer technology, Spinach™. Lucerna's products include plug-and-play RNA imaging systems and high-throughput screening platforms designed to accelerate medical research and drug development.

Notable figures affiliated with Lucerna include leading scientists in the field of RNA research. The company has attracted significant investment from prominent biotech venture capital firms. Key achievements include the successful commercialization of their Spinach™ technology and the development of innovative drug discovery platforms. Lucerna's impact is evident in its contribution to accelerating RNA-focused research, providing essential tools that enhance the understanding and treatment of various diseases.

Lucerna - Similar Companies

Lucid Scientific logo

Lucid Scientific

lucidsci.com

Lucerno Dynamics logo

Lucerno Dynamics

lucerno.com

Luceome Biotechnologies logo

Luceome Biotechnologies

luceome.com

Aurora Spectral Technologies logo

Aurora Spectral Technologies

Inceptive logo

Inceptive

inceptive.life

Laronde logo

Laronde

laronde.bio

Lucence logo

Lucence

lucence.com

Ochre Bio logo

Ochre Bio

ochre-bio.com

Locanabio logo

Locanabio

Nymirum logo

Nymirum

Base Pair Biotechnologies logo

Base Pair Biotechnologies

basepairbio.com

Curie.Bio logo

Curie.Bio

curie.bio

Lucendi logo

Lucendi

lucendi.org

Alltrna logo

Alltrna

alltrna.com

Ontera logo

Ontera

ontera.bio

Lucerna - Quick Facts

Who are Lucerna's competitors?

Companies similar to Lucerna include Lucid Scientific, Lucerno Dynamics, Luceome Biotechnologies and Aurora Spectral Technologies.

When was Lucerna founded?

Lucerna was founded in 2010.

Where is Lucerna's headquarters located?

Lucerna's headquarters is located in New York City, NY, US.

When was Lucerna's last funding round?

Lucerna's most recent funding round was for $149.7k (USD) in June 2013.

How much has Lucerna raised to-date?

As of Jun 21, 2013, Lucerna has raised a total of $149.7k (USD).

How many employees does Lucerna have?

Lucerna has 6 employees as of Feb 4, 2024.

Lucerna - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Research Reagents
Tags
  • API
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified